These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue. Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692 [TBL] [Abstract][Full Text] [Related]
47. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Rammsayer TH; Rodewald S; Groh D Brain Res Cogn Brain Res; 2000 Jan; 9(1):61-71. PubMed ID: 10666558 [TBL] [Abstract][Full Text] [Related]
48. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542 [TBL] [Abstract][Full Text] [Related]
49. Cognitive function in early clinical phase huntington disease after rivastigmine treatment. Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771 [TBL] [Abstract][Full Text] [Related]
50. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers. Veselinović T; Vernaleken I; Janouschek H; Kellermann T; Paulzen M; Cumming P; Gründer G Psychopharmacology (Berl); 2015 May; 232(9):1607-17. PubMed ID: 25373869 [TBL] [Abstract][Full Text] [Related]
51. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. van Ruitenbeek P; Vermeeren A; Riedel W J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925 [TBL] [Abstract][Full Text] [Related]
52. Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden. Gieling E; Wehkamp W; Willigenburg R; Nordquist RE; Ganderup NC; van der Staay FJ Behav Brain Funct; 2013 Jan; 9():4. PubMed ID: 23305134 [TBL] [Abstract][Full Text] [Related]
53. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Scholey AB; Tildesley NT; Ballard CG; Wesnes KA; Tasker A; Perry EK; Kennedy DO Psychopharmacology (Berl); 2008 May; 198(1):127-39. PubMed ID: 18350281 [TBL] [Abstract][Full Text] [Related]
54. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. Simioni S; Cavassini M; Annoni JM; Métral M; Iglesias K; Rimbault Abraham A; Jilek S; Calmy A; Müller H; Fayet-Mello A; Giacobini E; Hirschel B; Du Pasquier RA Neurology; 2013 Feb; 80(6):553-60. PubMed ID: 23345635 [TBL] [Abstract][Full Text] [Related]
55. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment. Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085 [TBL] [Abstract][Full Text] [Related]
56. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study. Bokde AL; Cavedo E; Lopez-Bayo P; Lista S; Meindl T; Born C; Galluzzi S; Faltraco F; Dubois B; Teipel SJ; Reiser M; Möller HJ; Hampel H Psychiatry Res Neuroimaging; 2016 Mar; 249():84-90. PubMed ID: 26851974 [TBL] [Abstract][Full Text] [Related]
58. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485 [TBL] [Abstract][Full Text] [Related]
59. Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study. Aasen I; Kumari V; Sharma T J Clin Psychopharmacol; 2005 Aug; 25(4):311-7. PubMed ID: 16012272 [TBL] [Abstract][Full Text] [Related]
60. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]